Biominas has already carried out the prospection of new technologies/products early and late-stage for differentes pharmaceutical companies, such as Roche, GSK, Sanofi and Ferring. In all, there were approximately 500 technologies mapped in different areas via active prospecting and opening of notices. Some of the results obtained include partnerships with startups, universities and incorporation of new products/services into the company’s innovation pipeline.
